Feasibility of weekly patient-reported symptom monitoring using patients’ own smartphones in outpatient cancer chemotherapy: the SMART-PRO study

Electronic patient-reported outcome (ePRO) systems using the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) can improve symptom monitoring, but the

Performance of large language models in delivering accurate and comprehensible patient information on heart failure and cardiomyopathy

BackgroundLarge language models (LLMs) are increasingly used by patients seeking cardiovascular health information through digital platforms. However, their accuracy and suitability for providing guidance on

Digital platforms for ethics review: a mini review

This mini review examines the emerging use of digital platforms for ethics review (DPER) and the extent to which research ethics committees (RECs) are prepared

Violet teaming as a resilient framework for bridging civilian-military electronic health record interoperability

The rapid digitization of healthcare through electronic health records (EHRs) and artificial intelligence (AI) is transforming clinical decision-making, data integration, and healthcare delivery. However, increasing

Voice disorders classification using machine learning: a scoping review

ObjectivesThis review aims to identify the key barriers to clinical application of Machine Learning (ML) in multi-class voice disorder classification.DesignScoping Review.MethodsA comprehensive scoping review of

The EU AI Act: implications and compliance guidance for healthcare facilities

June 10, 2026

BackgroundThe European Union AI Act [Regulation (EU) 2024/1689] establishes the first comprehensive legal framework for artificial intelligence. While AI offers transformative potential in healthcare, its deployment introduces risks regarding safety, bias, and accountability. There is currently a lack of practical operational frameworks to help healthcare facilities transition from legal theory to clinical compliance.MethodsWe performed a qualitative regulatory analysis of the EU AI Act, specifically focusing on the obligations of “deployers” (Articles 26, 27, and 50) in clinical settings. The Act’s requirements were cross-referenced with established clinical governance standards (e.g., MDR 2017/745 and FUTURE-AI guidelines). A 10-step compliance roadmap was synthesized and exemplified through a hypothetical case study of a high-risk multimodal breast cancer AI system.ResultsThe analysis identifies healthcare as a primary focus of the Act, with most clinical AI tools classified as “high-risk”. We established a four-phase implementation framework: (1) Foundational Strategy and Governance, (2) System Analysis & Risk Assessment, (3) Operational Integration, and (4) Ongoing Compliance. Key results include the definition of mandatory Fundamental Rights Impact Assessments (FRIA), requirements for site-specific technical validation, and the necessity of establishing trust through structured human oversight mechanisms to mitigate automation bias.ConclusionThe EU AI Act necessitates a shift from transactional procurement to a lifecycle-spanning compliance partnership between vendors and hospitals. While the administrative burden is substantial, the Act provides the essential framework for the safe scaling of medical AI. Proactive alignment with these standards, particularly regarding AI literacy and human oversight, is a strategic necessity for healthcare facilities to ensure patient safety and regulatory readiness by the August 2026 enforcement deadline.

Subscribe for Updates

Copyright 2025 dijee Intelligence Ltd. dijee Intelligence Ltd. is a private limited company registered in England and Wales at Media House, Sopers Road, Cuffley, Hertfordshire, EN6 4RY, UK registration number 16808844